US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
NL262354A
(ru)
*
|
1960-03-17 |
|
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
BE632504A
(ru)
*
|
1962-05-24 |
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
NL302251A
(ru)
*
|
1963-01-28 |
1965-10-11 |
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
FI770215A
(ru)
*
|
1976-01-30 |
1977-07-31 |
Fisons Ltd |
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
DE68915203T2
(de)
*
|
1988-03-22 |
1994-09-22 |
Fisons Plc |
Pharmazeutische Mischungen.
|
US5776434A
(en)
|
1988-12-06 |
1998-07-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
US5919435A
(en)
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
DE69231991T2
(de)
|
1991-06-10 |
2002-04-04 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
AU663905B2
(en)
*
|
1991-12-12 |
1995-10-26 |
Glaxo Group Limited |
Medicaments
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
ATE128350T1
(de)
*
|
1991-12-12 |
1995-10-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung.
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
ATE150296T1
(de)
|
1991-12-18 |
1997-04-15 |
Minnesota Mining & Mfg |
Aerosolzusammensetzungen für arzneimittelsuspensionen
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
KR100312357B1
(ko)
*
|
1992-12-09 |
2002-04-24 |
데이비드 이. 프랭크하우저 |
안정화된약제의에어로졸용액제제
|
ATE163006T1
(de)
*
|
1993-06-01 |
1998-02-15 |
Ono Pharmaceutical Co |
Pentansäurederivate
|
EP0640609A1
(en)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
CA2137106C
(en)
*
|
1993-12-03 |
2000-02-08 |
Hisao Nakai |
Amidinophenol derivatives
|
AU680967B2
(en)
*
|
1993-12-20 |
1997-08-14 |
Minnesota Mining And Manufacturing Company |
Flunisolide aerosol formulations
|
ES2132535T3
(es)
|
1994-09-20 |
1999-08-16 |
Ono Pharmaceutical Co |
Derivados de amidinofenol como inhibidores de proteasa.
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
DK0757984T3
(da)
*
|
1995-08-08 |
2003-03-03 |
Ono Pharmaceutical Co |
Hydroxamsyrederivater, der kan anvendes til inhibering af gelatinase
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
AU718967B2
(en)
|
1997-02-05 |
2000-05-04 |
Jagotec Ag |
Medical aerosol formulations
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするcDNA、そのcDNAからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
EP1100465B1
(de)
|
1998-07-24 |
2004-11-24 |
Jago Research Ag |
Medizinische aerosolformulierungen
|
US6475467B1
(en)
|
1998-08-04 |
2002-11-05 |
Jago Research Ag |
Medicinal aerosol formulations
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
WO2003009872A1
(en)
|
2001-07-23 |
2003-02-06 |
Ono Pharmaceutical Co., Ltd. |
Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
|
DE60336890D1
(de)
|
2002-02-19 |
2011-06-09 |
Ono Pharmaceutical Co |
Kondensierte pyridazinderivat-verbindungen und die verbindungen als wirkstoff enthaltende arzneimittel
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
NZ537360A
(en)
*
|
2002-06-25 |
2006-09-29 |
Acrux Dds Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
TW200410688A
(en)
|
2002-06-26 |
2004-07-01 |
Ono Pharmaceutical Co |
Therapeutics for diseases from vasoconstriction or vasodilatation
|
EP2243493A1
(en)
|
2002-07-03 |
2010-10-27 |
Ono Pharmaceutical Co., Ltd. |
Immunopotentiative composition
|
JP4691988B2
(ja)
|
2002-10-03 |
2011-06-01 |
小野薬品工業株式会社 |
Lpa受容体拮抗剤
|
TW200413000A
(en)
|
2002-10-10 |
2004-08-01 |
Ono Pharmaceutical Co |
Intrinsic repair factor producing accelerator
|
WO2004032964A1
(ja)
*
|
2002-10-10 |
2004-04-22 |
Ono Pharmaceutical Co., Ltd. |
アレルギー性疾患治療剤
|
EP2270051B1
(en)
|
2003-01-23 |
2019-05-15 |
Ono Pharmaceutical Co., Ltd. |
Antibody specific for human PD-1 and CD3
|
JP4736043B2
(ja)
|
2003-03-14 |
2011-07-27 |
小野薬品工業株式会社 |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
WO2004092169A1
(ja)
|
2003-04-18 |
2004-10-28 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
CA2526222A1
(en)
*
|
2003-05-16 |
2004-12-02 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease associated with matrix metalloprotease inhibitors
|
US20050069918A1
(en)
*
|
2003-05-29 |
2005-03-31 |
Francois Claret |
JAB1 as a prognostic marker and a therapeutic target for human cancer
|
EP2422814A1
(en)
|
2003-07-25 |
2012-02-29 |
Ono Pharmaceutical Co., Ltd. |
Remedy for cartilage-related diseases
|
JP4947406B2
(ja)
|
2003-08-29 |
2012-06-06 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその医薬用途
|
WO2005021518A1
(ja)
|
2003-09-01 |
2005-03-10 |
Ono Pharmaceutical Co., Ltd. |
縮環化合物およびその用途
|
JP2007505136A
(ja)
*
|
2003-09-10 |
2007-03-08 |
マツプ・フアーマシユーテイカルズ・インコーポレーテツド |
ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
|
JP2007509147A
(ja)
*
|
2003-10-20 |
2007-04-12 |
シェーリング コーポレイション |
薬学的エアロゾル組成物
|
EP1698375B1
(en)
|
2003-12-25 |
2014-04-02 |
Ono Pharmaceutical Co., Ltd. |
Azetidine ring compounds and drugs comprising the same
|
US20060018840A1
(en)
*
|
2004-06-28 |
2006-01-26 |
Nektar Therapeutics |
Aerosolizable formulation comprising nicotine
|
JP5272310B2
(ja)
|
2004-10-21 |
2013-08-28 |
小野薬品工業株式会社 |
免疫抑制受容体の用途
|
DE602005016833D1
(de)
*
|
2004-11-24 |
2009-11-05 |
Alcon Inc |
Verfahren zur Verabreichung eines Nasensprays
|
WO2006084041A2
(en)
|
2005-02-02 |
2006-08-10 |
Mitos Pharmaceuticals, Inc. |
Nitroxides for use in treating or preventing diabetes
|
US8546423B2
(en)
*
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
DK1901749T3
(en)
|
2005-05-18 |
2016-10-24 |
Raptor Pharmaceuticals Inc |
Aerosolized fluoroquinolones AND USES THEREOF
|
CN107496925A
(zh)
|
2005-06-17 |
2017-12-22 |
威斯康星校友研究基金会 |
在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法
|
EP2657235A1
(en)
|
2005-10-28 |
2013-10-30 |
Ono Pharmaceutical Co., Ltd. |
Compound containing basic group and use thereof
|
JPWO2007069565A1
(ja)
|
2005-12-12 |
2009-05-21 |
小野薬品工業株式会社 |
二環式複素環化合物
|
US20100184771A1
(en)
|
2005-12-15 |
2010-07-22 |
Ono Pharmaceutical Co., Ltd. |
Bicyclic Heterocyclic Compound
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
EP2425820B1
(en)
*
|
2007-02-11 |
2015-04-08 |
MAP Pharmaceuticals Inc |
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
PT2346509T
(pt)
|
2008-10-07 |
2020-08-05 |
Horizon Orphan Llc |
Inalação de levofloxacina para redução da inflamação pulmonar
|
NO2344129T3
(ru)
|
2008-10-07 |
2018-07-21 |
|
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
US8569504B2
(en)
|
2009-06-17 |
2013-10-29 |
Ono Pharmaceutical Co., Ltd. |
Imidazopyridine compound
|
US20110171141A1
(en)
*
|
2009-06-26 |
2011-07-14 |
Kellerman Donald J |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
SI2473170T1
(sl)
|
2009-09-04 |
2019-10-30 |
Horizon Orphan Llc |
Uporaba aerosoliziranega levofloksacina za zdravljenje cistične fibroze
|
US8853277B2
(en)
|
2009-11-30 |
2014-10-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
|
ES2572804T3
(es)
|
2010-06-21 |
2016-06-02 |
Ono Pharmaceutical Co., Ltd. |
Nuevas formas cristalinas de ácido 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-metilfenil)butoxi]fenil}etinil)2-metil-1H-indol-1,3-diil]butanoico
|
JP5423905B2
(ja)
|
2010-12-02 |
2014-02-19 |
小野薬品工業株式会社 |
新規化合物及びその医薬用途
|
AU2012212269B2
(en)
|
2011-01-31 |
2016-05-19 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
ES2587856T3
(es)
|
2011-03-18 |
2016-10-27 |
Ono Pharmaceutical Co., Ltd. |
Derivado de tetrahidrocarbolina
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|
MX353336B
(es)
|
2013-02-19 |
2018-01-09 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
CA3172586A1
(en)
|
2013-07-31 |
2015-02-05 |
Avalyn Pharma Inc. |
Aerosol imatininb compounds and uses thereof
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US10016439B2
(en)
|
2014-01-31 |
2018-07-10 |
Ono Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
WO2018101309A1
(ja)
|
2016-11-30 |
2018-06-07 |
大日本住友製薬株式会社 |
Wt1ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
|
WO2018181648A1
(ja)
|
2017-03-30 |
2018-10-04 |
大日本住友製薬株式会社 |
Wt1癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体
|
WO2019049891A1
(ja)
|
2017-09-06 |
2019-03-14 |
小野薬品工業株式会社 |
Trk阻害剤とキナーゼ阻害剤の併用による癌治療方法
|
AU2019277632A1
(en)
|
2018-05-31 |
2020-12-24 |
National Cancer Center Japan |
Biomarker for judging efficacy of immune checkpoint inhibitor
|
TW202028212A
(zh)
|
2018-10-11 |
2020-08-01 |
日商小野藥品工業股份有限公司 |
Sting促效化合物
|
MX2022001434A
(es)
|
2019-08-05 |
2022-02-22 |
Ono Pharmaceutical Co |
Biomarcadores para determinar la eficacia de los inhibidores de puntos de control inmunitarios.
|
JPWO2021107125A1
(ru)
|
2019-11-29 |
2021-06-03 |
|
|
EP4134134A4
(en)
|
2020-04-10 |
2023-12-27 |
ONO Pharmaceutical Co., Ltd. |
STING AGONIST COMPOUND
|
KR20230009426A
(ko)
|
2020-05-12 |
2023-01-17 |
스미토모 파마 가부시키가이샤 |
암을 처치하기 위한 의약 조성물
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|